Global mergers

Threat from big pharma

Print edition : May 30, 2014

A view of AstraZeneca's manufacturing site in Macclesfield, England. U.S. pharma major Pfizer has advanced a $100-billion-plus bid to takeover the British drug major. The move seemingly has the backing of the David Cameron government in the United Kingdom. Photo: DARREN STAPLES/REUTERS

    This article is closed for comments.
    Please Email the Editor